Initial report of a single institution experience with teclistamab for relapsed or refractory multiple myeloma including prior BCMA

被引：0

作者：

Faiman, Beth ^{[1
]}

Dima, Danai ^{[1
]}

Duco, Marissa ^{[1
]}

Rice, Mikhaila ^{[1
]}

Rudoni, Joslyn ^{[1
]}

Anwer, Faiz ^{[1
]}

Khouri, Jack ^{[1
]}

Mazzoni, Sandra ^{[1
]}

Raza, Shahzad ^{[1
]}

Samaras, Christy ^{[1
]}

Williams, Louis ^{[1
]}

Valent, Jason ^{[1
]}

机构：

[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-256

引用

页码：S177 / S177

页数：1

共 50 条

[41] MANAGING INFECTION RISK IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: NURSING EXPERIENCE WITH TECLISTAMAB IN THE MAJESTEC-1 STUDY [J].

Kruyswijk, Sandy ;

van de Donk, Niels ;

Doyle, Margaret ;

Chastain, Katherine ;

Trancucci, Danielle ;

Catamero, Donna .

ONCOLOGY NURSING FORUM, 2024, 51 (02)

[42] MANAGING CYTOKINE RELEASE SYNDROME IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXPERIENCE WITH TECLISTAMAB IN THE MAJESTEC-1 STUDY [J].

Catamero, Donna ;

Blazquez, Patricia ;

Shenoy, Samantha ;

Chastain, Katherine ;

Kruyswijk, Sandy .

ONCOLOGY NURSING FORUM, 2023, 50 (02)

[43] First report of teclistamab in a patient with relapsed AL amyloidosis and multiple myeloma [J].

Leung, Nelson ;

Chapman, Jennifer A. ;

Bhatia, Sumeet .

EJHAEM, 2023, 4 (04) :1157-1159

[44] Efficacy of teclistamab in patients (pts) with heavily pretreated, relapsed/refractory multiple myeloma (RRMM), including those refractory to penta RRMM and BCMA (B-cell maturation antigen) directed therapy (BDT) [J].

Venkatesh, Priyanka ;

Atrash, Shebli ;

Paul, Barry ;

Alkharabsheh, Omar ;

Afrough, Aimaz ;

Mahmoudjafari, Zahra ;

Mushtaq, Muhammad Umair ;

Hashmi, Hamza ;

Davis, James A. ;

Abdallah, Al-Ola A. .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

[45] BCMA x CD3 bispecific antibody treatment with teclistamab in relapsed and/or refractory multiple myeloma: a real-world monocentric analysis [J].

Schaefers, C. ;

Thiele, B. ;

Alsdorf, W. ;

Kosch, R. ;

Leypoldt, L. ;

Bokemeyer, C. ;

Weisel, K. ;

Kamili, A. .

ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 :312-312

[46] Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States [J].

Gordan, Lucio N. ;

Bensimon, Arielle G. ;

Mu, Fan ;

Kim, Nina ;

Wu, Bingcao ;

Lin, Dee ;

Paner, Agne ;

Fowler, Jessica ;

Marshall, Alex ;

Van Sanden, Suzy ;

Ammann, Eric ;

Goble, Joe ;

Zhang, Xinke ;

Le, Hoa H. ;

Min, Elissa E. ;

Garrison, Louis P. .

JOURNAL OF MEDICAL ECONOMICS, 2025, 28 (01) :910-920

[47] Pharmacodynamics of SEA-BCMA, a Nonfucosylated Antibody Targeting BCMA, in Patients with Relapsed/Refractory Multiple Myeloma [J].

Taft, David ;

Henderson, Clark ;

O'Day, Christine ;

Yu, Changpu ;

Li, Hong ;

Ho, Phoenix ;

Van Epps, Heather .

BLOOD, 2021, 138

[48] Isatuximab monotherapy or combination therapy with dexamethasone in older adult patients with relapsed/refractory multiple myeloma: a single institution experience [J].

Iino, Masaki ;

Mikawa, Takahiro ;

Kido, Shinji ;

Fujimori, Ken .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 :S186-S186

[49] Real-World Evaluation of Teclistamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM) [J].

Asoori, Sireesha ;

Popat, Rakesh ;

Martinez-Lopez, Joaquin ;

Kastritis, Efstathios ;

Brunaldi, Larissa ;

Bansal, Radhika ;

Corraes, Andre De Menezes Silva ;

Yong, Kwee ;

Mactier, Catriona ;

Corona, Magdalena ;

Saez Marin, Adolfo Jesus ;

Fotiou, Despina ;

Dimopoulos, Meletios Athanasios ;

Chhabra, Saurabh ;

Ailawadhi, Sikander ;

Parrondo, Ricardo ;

Martin, Thomas ;

Durie, Brian G. M. ;

Lin, Yi .

BLOOD, 2023, 142

[50] Tocilizumab Prophylaxis for Patients with Relapsed or Refractory Multiple Myeloma Treated with Teclistamab, Elranatamab or Talquetamab [J].

Kowalski, Andrew ;

Lykon, Jill ;

Diamond, Benjamin ;

Coffey, David G. ;

Kaddoura, Marcella ;

Maura, Francesco ;

Hoffman, James E. ;

Kazandjian, Dickran ;

Landgren, Ola .

BLOOD, 2024, 144 :933-933

← 1 2 3 4 5 →